Dominique Durand

Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C.

L. Rostaing, D. Durand, J. Cisterne, 1996, Nephron.

T-cell function in maintenance renal transplant patients receiving mycophenolate mofetil and steroids with or without tacrolimus.

S. Galvani, Nassim Kamar, L. Rostaing, 2008, Transplantation proceedings.

Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications.

L. Rostaing, J. Izopet, C. Thalamas, 1998, Journal of the American Society of Nephrology : JASN.

A third renal transplantation: is it relevant and is it worth it?

L. Rostaing, N. Kamar, D. Durand, 2005, Transplantation proceedings.

Daclizumab Versus Rabbit Antithymocyte Globulin in High‐Risk Renal Transplants: Five‐Year Follow‐up of a Randomized Study

J. Squifflet, D. Abramowicz, F. Berthoux, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients.

L. Rostaing, N. Kamar, D. Durand, 2006, Transplantation proceedings.

Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients.

C. Pasquier, L. Rostaing, J. Puel, 2000, The Journal of infectious diseases.

Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients.

L. Rostaing, D. Durand, M. Abbal, 1994, American journal of nephrology.

Long-term impact of superinfection by hepatitis G virus in hepatitis C virus-positive renal transplant patients.

L. Rostaing, J. Izopet, D. Durand, 1999, Transplantation.